Firm type · Focus area

Genetics Private Equity Firms

The RaiseHunt database lists 66 Genetics private equity firms: all of them list a portfolio, 637 known investments between them and 607 people at those firms have a profile here. That is the overlap between 7,421 private equity firms and 227 Genetics investment firms. Most list Late-Stage and Growth among the rounds they take part in; the largest concentrations are in New York, Boston and San Francisco.

Part of private equity firms and Genetics investment firms.

Strongest in New York, Boston and San Francisco

Backing rounds at Late-Stage and Growth

66: Investment firms
66: With a known portfolio
637: Known investments
607: People with a profile

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

66 Genetics private equity firms

Showing 61-66

Filters

Viewing

Private equity7,421 Genetics227

Firm type1

See all 10→

Investment stage

Choosing one replaces Genetics.

Late-Stage5,420
Seed3,293
Growth2,673
Series A2,319
Series B2,014
Pre-Seed520

See all 6→

Sector

Choosing one replaces Genetics.

Healthcare2,559
FinTech2,369
SaaS2,133
Hardware2,115
Consumer2,018
Real Estate1,584
Commerce1,579
Climate1,435
AI1,280
Food714
Education494
Travel437

See all 14→

Focus area1

See all 365→

Firm	Location	Type	Markets	Actions
Merifin Capital	London, United Kingdom	Private equityVenture capital	CommerceHardware	View fund
YI Yuantai Investment Partners	Shanghai, China	Private equity	HardwareHealthcare	View fund
Bunker Hill Capital	Boston, United States	Private equity	ConsumerHardware	View fund
Elysian Capital	London, United Kingdom	Private equity		View fund
C Careventures	Barcelona, Spain	Private equity	Healthcare	View fund
DP Dreamstone Partners	Seoul, South Korea	Private equityVenture capital	HealthcareReal Estate	View fund

Data: RaiseHunt investor dataset · Snapshot 2 October 2026 · How this data is built · Report a correction or request removal